Evidence map›Paper›PMID 34362727›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2021

Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination.

Julie Robichaud, Catherine Côté, Fanny Côté

Abstract readCase Reports
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. The systemic capillary leak syndrome following COVID-19 vaccine.Human vaccines & immunotherapeutics · 2024
    Article
  3. Systemic capillary leak syndrome.Nature reviews. Disease primers · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julie RobichaudDepartments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que. julie.robichaud.med@ssss.gouv.qc.ca.
Catherine CôtéDepartments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que.
Fanny CôtéDepartments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedCapillary Leak SyndromeChAdOx1 nCoV-19COVID-19COVID-19 VaccinesHumansMaleVaccinationChAdOx1 nCoV-19COVID-19 Vaccines

Identifiers

PMID34362727
PMCPMC8432311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.